Advertisement

Organisation › Details
Activiomics Ltd.
Headquartered in London, UK, Activiomics Ltd. is a privately owned spin-out company from the Barts Cancer Institute (BCI), ranked one of the top five cancer research centres in the UK and a Queen Mary University of London campus. The company was founded in 2009 through investment from a number of sources including IP Group. Activiomics has developed a ground-breaking patented technology that will enable a transformation in the way in which biomarkers are identified, diagnostics are developed and drug candidates are identified and profiled. Activiomics' technology centres around novel mass spectrometry based approaches for the global quantitative analysis of the proteome and of the phosphorylation status of cells and tissues. Phosphorylation is a critical mediator in all cellular processes and hence phosphorylated proteins represent an important class of novel biomarkers. Activiomics' TIQUAS (Targeted In-depth QUAntification of cell Signalling) technology enables the quantification of thousands of phosphorylation events from a given cell or tissue sample and the subsequent markers of response that are identified will enable the development of future diagnostics. Activiomics is using exclusively accessed primary breast cancer samples to generate proof-of-concept data and high value data packages for novel predictive and prognostic markers of disease. Additionally, Activiomics commercialises its technology by partnering directly with large pharmaceutical and biotechnology companies in bespoke programmes of work. Recent partners include Genentech, UCB and GlaxoSmithKline. *
![]() |
Start | 2010-03-01 splitoff (date ca.) |
Group | Retroscreen Virology (Group) | |
Predecessor | Queen Mary, University of London, Institute of Cancer | |
![]() |
Industry | mass spectrometry technology |
Industry 2 | TIQUAS technology (Targeted In-depth Quantification of cell Signalling) | |
![]() |
Person | FitzGerald, Kevin (Activiomics 201304– CEO F-Star 201104–201205 CEO LEFT 5/12 + Isogenica + CAT) |
Person 2 | Warne, Mark (IP Group 201411 Healthcare Portfolio Director + Activiomics 201004 Interim CEO) | |
![]() |
Region | London, Greater London |
Country | United Kingdom (GB) | |
Street | 24 Cornhill | |
City | EC3V 3ND London | |
Tel | +44-845-5195-091 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | GBP | |
Profit | -500,000 (2013-07-31) | |
* Document for �About Section�: BioFocus. (9/19/13). "Press Release: Activiomics Extends Research Agreement with Kyowa Hakko Kirin as Part of Its Strategic Partnership with BioFocus". | ||
Record changed: 2019-06-09 |
Advertisement

More documents for Retroscreen Virology (Group)
- [1] Retroscreen Virology Group plc. (3/4/14). "Press Release: Acquisition [of Activiomics Ltd.]"....
- [2] Activiomics Ltd.. (9/30/13). "Press Release: Activiomics Extends Capability to Clinical Biomarker Discovery and Appoints CEO". London....
- [3] BioFocus. (9/19/13). "Press Release: Activiomics Extends Research Agreement with Kyowa Hakko Kirin as Part of Its Strategic Partnership with BioFocus"....
- [4] Activiomics Ltd.. (11/22/12). "Press Release: Activiomics Signs Research Agreement with Kyowa Hakko Kirin as Part of Its Strategic Partnership with BioFocus"....
- [5] BioFocus. (7/25/12). "Press Release: BioFocus Expands Its Drug Discovery Offering with Proteomics Technology from Activiomics"....
- [6] Activiomics Ltd.. (3/27/12). "Press Release: Biomarker Specialist Activiomics Appoints Dr Trevor Nicholls as Non-executive Chairman". London....
- [7] Activiomics Ltd.. (3/14/11). "Press Release: Biomarker Specialist Activiomics Receives Investment from IP Group plc. Investment in Queen Mary, University of London Spin-out to Fund Growth Strategy"....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
![Picture [iito] Männer Ballett 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-maenner-ballett.jpg)
» top